Back to 
Centiva Capital, LP
Centiva Capital, LP
AKBA
Showing 0 of 2 quarters
Position history for Centiva Capital, LP's holdings in Akebia Therapeutics, Inc.
No. Centiva Capital exited its AKBA (Akebia Therapeutics) position in Q3 2022. Its Q2 2022 13F listed 13,638 shares worth $5,000. Centiva Capital first reported AKBA in Q2 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.